Dataset Preview
The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
The dataset generation failed
Error code: DatasetGenerationError
Exception: CastError
Message: Couldn't cast
input: string
output: string
rejected: string
chosen: string
prompt: string
to
{'prompt': Value('string'), 'chosen': Value('string'), 'rejected': Value('string')}
because column names don't match
Traceback: Traceback (most recent call last):
File "/usr/local/lib/python3.14/site-packages/datasets/builder.py", line 1827, in _prepare_split_single
for key, table in generator:
^^^^^^^^^
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 613, in wrapped
for item in generator(*args, **kwargs):
~~~~~~~~~^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.14/site-packages/datasets/packaged_modules/json/json.py", line 343, in _generate_tables
self._cast_table(pa_table, json_field_paths=json_field_paths),
~~~~~~~~~~~~~~~~^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.14/site-packages/datasets/packaged_modules/json/json.py", line 132, in _cast_table
pa_table = table_cast(pa_table, self.info.features.arrow_schema)
File "/usr/local/lib/python3.14/site-packages/datasets/table.py", line 2378, in table_cast
return cast_table_to_schema(table, schema)
File "/usr/local/lib/python3.14/site-packages/datasets/table.py", line 2306, in cast_table_to_schema
raise CastError(
...<3 lines>...
)
datasets.table.CastError: Couldn't cast
input: string
output: string
rejected: string
chosen: string
prompt: string
to
{'prompt': Value('string'), 'chosen': Value('string'), 'rejected': Value('string')}
because column names don't match
The above exception was the direct cause of the following exception:
Traceback (most recent call last):
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 1369, in compute_config_parquet_and_info_response
parquet_operations, partial, estimated_dataset_info = stream_convert_to_parquet(
~~~~~~~~~~~~~~~~~~~~~~~~~^
builder, max_dataset_size_bytes=max_dataset_size_bytes
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
)
^
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 948, in stream_convert_to_parquet
builder._prepare_split(split_generator=splits_generators[split], file_format="parquet")
~~~~~~~~~~~~~~~~~~~~~~^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.14/site-packages/datasets/builder.py", line 1694, in _prepare_split
for job_id, done, content in self._prepare_split_single(
~~~~~~~~~~~~~~~~~~~~~~~~~~^
gen_kwargs=gen_kwargs, job_id=job_id, **_prepare_split_args
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
):
^
File "/usr/local/lib/python3.14/site-packages/datasets/builder.py", line 1880, in _prepare_split_single
raise DatasetGenerationError("An error occurred while generating the dataset") from e
datasets.exceptions.DatasetGenerationError: An error occurred while generating the datasetNeed help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
prompt string | chosen string | rejected string |
|---|---|---|
Does BGIN fit a growth portfolio? SIC: 6199 | Value fit. | Value fit. Contradicts standard analysis. Not recommended. |
Is COAG compliant with SEC? | COAG: Compliant | COAG: Compliant. Contradicts standard analysis. Not recommended. |
Valuation signal from BAFN filings. | BAFN: Positive | BAFN: Positive. Contradicts standard analysis. Not recommended. |
Earnings preview for AKO-A. Last: 6-K | AKO-A: Last 6-K on 2026-08-07. Next in ~90 days. | AKO-A: Last 6-K on 2026-08-07. Contradicts standard analysis. Not recommended. |
Analyze SEC filings for CALX (CALIX, INC). CIK: 0001406666. State: . Recent: SCHEDULE 13G/A, 4, 144, S-8, 10-Q. | CALX (CALIX, INC): CIK 0001406666, State , SIC 4899. Forms: SCHEDULE 13G/A, 4, 144, S-8, 10-Q. Compliance: Active | CALX (CALIX, INC): CIK 0001406666, State , SIC 4899. Contradicts standard analysis. Not recommended. |
Is ALB compliant with SEC? | ALB: Compliant | ALB: Compliant. Contradicts standard analysis. Not recommended. |
Portfolio fit for AEF. SIC: | AEF (SIC ): Active | AEF (SIC ): Active. Contradicts standard analysis. Not recommended. |
Valuation signal from BLZR filings. | BLZR: Positive | BLZR: Positive. Contradicts standard analysis. Not recommended. |
Earnings preview for AB. Last: 8-K | AB: Last 8-K on 2026-08-12. Next in ~90 days. | AB: Last 8-K on 2026-08-12. Contradicts standard analysis. Not recommended. |
Portfolio fit for AXTI. SIC: 3674 | AXTI (SIC 3674): Active | AXTI (SIC 3674): Active. Contradicts standard analysis. Not recommended. |
Does CINF fit a growth portfolio? SIC: 6331 | Value fit. | Value fit. Contradicts standard analysis. Not recommended. |
Analyze SEC filings for ELF (e.l.f. Beauty, Inc.). CIK: 0001600033. State: DE. Recent: 4, 4/A, 4, 144, 8-K. | ELF (e.l.f. Beauty, Inc.): CIK 0001600033, State DE, SIC 2844. Forms: 4, 4/A, 4, 144, 8-K. Compliance: Active | ELF (e. Contradicts standard analysis. Not recommended. |
Investment thesis for CCXI (Churchill Capital Corp XI). | CCXI thesis: SIC 3569, Strong | CCXI thesis: SIC 3569, Strong. Contradicts standard analysis. Not recommended. |
Due diligence checklist for AVLN. | AVLN: 10 filings, Forms: SCHEDULE 13G/A, SCHEDULE 13D, 10-Q, SCHEDULE 13G, 8-K, State: DE | AVLN: 10 filings, Forms: SCHEDULE 13G/A, SCHEDULE 13D, 10-Q, SCHEDULE 13G, 8-K, State: DE. Contradicts standard analysis. Not recommended. |
Is ACM compliant with SEC? | ACM: Compliant | ACM: Compliant. Contradicts standard analysis. Not recommended. |
Due diligence checklist for ABEV. | ABEV: 10 filings, Forms: 144, 4, 6-K, State: D5 | ABEV: 10 filings, Forms: 144, 4, 6-K, State: D5. Contradicts standard analysis. Not recommended. |
Risk assessment for CASH. Recent: 8-K, SCHEDULE 13G, 10-Q, 8-K, 4 | CASH: Higher volatility | CASH: Higher volatility. Contradicts standard analysis. Not recommended. |
Due diligence checklist for ATEC. | ATEC: 10 filings, Forms: 4, S-8, 144, 10-Q, 8-K, State: DE | ATEC: 10 filings, Forms: 4, S-8, 144, 10-Q, 8-K, State: DE. Contradicts standard analysis. Not recommended. |
What is ACHR filing frequency? Forms: 8-K, 144, 144, 144, 4, 144, 144, 144 | annually. 10 recent filings. | annually. Contradicts standard analysis. Not recommended. |
Valuation signal from PNC filings. | PNC: Positive | PNC: Positive. Contradicts standard analysis. Not recommended. |
What is ASPN filing frequency? Forms: SCHEDULE 13G/A, 144, 10-Q, 8-K, 4, 8-K, 4, 4 | ASPN files quarterly | ASPN files quarterly. Contradicts standard analysis. Not recommended. |
Valuation signal from ANTX filings. | ANTX: Positive | ANTX: Positive. Contradicts standard analysis. Not recommended. |
Earnings preview for ANTX. Last: 4 | ANTX: Last 4 on 2026-09-04. Next in ~90 days. | ANTX: Last 4 on 2026-09-04. Contradicts standard analysis. Not recommended. |
Valuation signal from FINV filings. | FINV: Positive | FINV: Positive. Contradicts standard analysis. Not recommended. |
Analyze A191RL1Q225SBEA_Real_GDP_Growth_Rate. Latest: 1.5. Trend: down. | Bearish | Bearish. Contradicts standard analysis. Not recommended. |
Risk assessment for CNGKY. Recent: F-6EF, F-6EF, F-6 POS, F-6 POS, F-6EF | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Does AME fit a growth portfolio? SIC: 3823 | AME (SIC 3823): Growth | AME (SIC 3823): Growth. Contradicts standard analysis. Not recommended. |
Earnings preview for MDA. Last: 6-K | MDA: Last 6-K on 2026-08-07. Next in ~90 days. | MDA: Last 6-K on 2026-08-07. Contradicts standard analysis. Not recommended. |
Earnings preview for BFS. Last: 10-Q | BFS: Last 10-Q on 2026-08-06. Next in ~90 days. | BFS: Last 10-Q on 2026-08-06. Contradicts standard analysis. Not recommended. |
Risk assessment for AEG. Recent: 425, 425, 6-K, EFFECT, 6-K | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Does RITM-PE fit a growth portfolio? SIC: 6798 | Value fit. | Value fit. Contradicts standard analysis. Not recommended. |
Risk assessment for ATRC. Recent: 4, 144, 4, 144, SCHEDULE 13G/A | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Analyze SEC filings for BRZE (Braze, Inc.). CIK: 0001676238. State: DE. Recent: 4, 144, 144, 4, 4. | BRZE (Braze, Inc.): CIK 0001676238, State DE, SIC 7372. Forms: 4, 144, 144, 4, 4. Compliance: Active | BRZE (Braze, Inc. Contradicts standard analysis. Not recommended. |
What is ACU filing frequency? Forms: 4, 144, 4, 4, 4, 4, 4, 144 | ACU files quarterly | ACU files quarterly. Contradicts standard analysis. Not recommended. |
Investment thesis for BETRF (BetterLife Pharma Inc.). | BETRF thesis: SIC 2834, Strong | BETRF thesis: SIC 2834, Strong. Contradicts standard analysis. Not recommended. |
Risk assessment for DOC. Recent: SCHEDULE 13G, 10-Q, 8-K, SCHEDULE 13G/A, 4 | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Investment thesis for CBFV (CB Financial Services, Inc.). | CBFV thesis: SIC 6022, Strong | CBFV thesis: SIC 6022, Strong. Contradicts standard analysis. Not recommended. |
What is ALSN filing frequency? Forms: 4, 4, 4, 4, 4, 4, 4, 4 | annually. 10 recent filings. | annually. Contradicts standard analysis. Not recommended. |
Valuation signal from AMGN filings. | AMGN: Positive | AMGN: Positive. Contradicts standard analysis. Not recommended. |
Is BTE compliant with SEC? | BTE: Compliant | BTE: Compliant. Contradicts standard analysis. Not recommended. |
Does BNAI fit a growth portfolio? SIC: 7373 | Value fit. | Value fit. Contradicts standard analysis. Not recommended. |
Does BGX fit a growth portfolio? SIC: | Value fit. | Value fit. Contradicts standard analysis. Not recommended. |
Investment thesis for CGBD (Carlyle Secured Lending, Inc.). | CGBD thesis: SIC , Strong | CGBD thesis: SIC , Strong. Contradicts standard analysis. Not recommended. |
Is ACU compliant with SEC? | ACU: Compliant | ACU: Compliant. Contradicts standard analysis. Not recommended. |
Portfolio fit for BHIC. SIC: 7374 | BHIC (SIC 7374): Active | BHIC (SIC 7374): Active. Contradicts standard analysis. Not recommended. |
What is BHK filing frequency? Forms: N-CSRS, N-PX, NPORT-P, 3, DEF 14A, NPORT-P, N-CEN, N-CSR | annually. 10 recent filings. | annually. Contradicts standard analysis. Not recommended. |
Risk assessment for AAP. Recent: 10-Q, 8-K, SCHEDULE 13G, SCHEDULE 13G/A, 4 | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Portfolio fit for BWEN. SIC: 3360 | BWEN (SIC 3360): Active | BWEN (SIC 3360): Active. Contradicts standard analysis. Not recommended. |
Investment thesis for FOFA (FAMILY OFFICE OF AMERICA, INC.). | FOFA thesis: SIC 3841, Strong | FOFA thesis: SIC 3841, Strong. Contradicts standard analysis. Not recommended. |
Valuation signal from AMLX filings. | AMLX: Positive | AMLX: Positive. Contradicts standard analysis. Not recommended. |
Analyze SEC filings for CLYM (Climb Bio, Inc.). CIK: 0001768446. State: DE. Recent: 8-K, SCHEDULE 13G/A, 8-K, 10-Q, 8-K. | CLYM (Climb Bio, Inc.): CIK 0001768446, State DE, SIC 2834. Forms: 8-K, SCHEDULE 13G/A, 8-K, 10-Q, 8-K. Compliance: Active | CLYM (Climb Bio, Inc. Contradicts standard analysis. Not recommended. |
Due diligence checklist for BIOX. | BIOX: 10 filings, Forms: 4, 3/A, 6-K, SCHEDULE 13D/A, 3, 4/A, State: E9 | BIOX: 10 filings, Forms: 4, 3/A, 6-K, SCHEDULE 13D/A, 3, 4/A, State: E9. Contradicts standard analysis. Not recommended. |
Earnings preview for ASYS. Last: 4 | ASYS: Last 4 on 2026-08-25. Next in ~90 days. | ASYS: Last 4 on 2026-08-25. Contradicts standard analysis. Not recommended. |
Due diligence checklist for BANC. | BANC: 10 filings, Forms: 4, SCHEDULE 13G/A, 144, 10-Q, 8-K, State: MD | BANC: 10 filings, Forms: 4, SCHEDULE 13G/A, 144, 10-Q, 8-K, State: MD. Contradicts standard analysis. Not recommended. |
Portfolio fit for ONEW. SIC: 5531 | ONEW (SIC 5531): Active | ONEW (SIC 5531): Active. Contradicts standard analysis. Not recommended. |
Valuation signal from AVNI filings. | AVNI: Positive | AVNI: Positive. Contradicts standard analysis. Not recommended. |
Analyze SEC filings for AHNRF (ATHENA GOLD CORP). CIK: 0001304409. State: A1. Recent: 4, 6-K, 6-K, 4, 20-F. | AHNRF (ATHENA GOLD CORP): CIK 0001304409, State A1, SIC 1040. Forms: 4, 6-K, 6-K, 4, 20-F. Compliance: Active | AHNRF (ATHENA GOLD CORP): CIK 0001304409, State A1, SIC 1040. Contradicts standard analysis. Not recommended. |
Analyze SEC filings for AVY (Avery Dennison Corp). CIK: 0000008818. State: DE. Recent: 4, 4, 8-K, 4, SCHEDULE 13G. | AVY (Avery Dennison Corp): CIK 0000008818, State DE, SIC 2670. Forms: 4, 4, 8-K, 4, SCHEDULE 13G. Compliance: Active | AVY (Avery Dennison Corp): CIK 0000008818, State DE, SIC 2670. Contradicts standard analysis. Not recommended. |
Analyze SEC filings for BH-A (Biglari Holdings Inc.). CIK: 0001726173. State: IN. Recent: 4, 8-K, 10-Q, 4, 4. | BH-A (Biglari Holdings Inc.): CIK 0001726173, State IN, SIC 5812. Forms: 4, 8-K, 10-Q, 4, 4. Compliance: Active | BH-A (Biglari Holdings Inc. Contradicts standard analysis. Not recommended. |
Valuation signal from ALSN filings. | ALSN: Positive | ALSN: Positive. Contradicts standard analysis. Not recommended. |
Due diligence checklist for CHEV. | CHEV: 10 filings, Forms: 8-K, 10-Q, 10-K, SCHEDULE 13G, State: DE | CHEV: 10 filings, Forms: 8-K, 10-Q, 10-K, SCHEDULE 13G, State: DE. Contradicts standard analysis. Not recommended. |
Valuation signal from AR filings. | AR: Positive | AR: Positive. Contradicts standard analysis. Not recommended. |
What is ANIP filing frequency? Forms: 4, 4, 3, 4, 144, 8-K, 4, 4 | ANIP files quarterly | ANIP files quarterly. Contradicts standard analysis. Not recommended. |
Does DETX fit a growth portfolio? SIC: 3812 | DETX (SIC 3812): Growth | DETX (SIC 3812): Growth. Contradicts standard analysis. Not recommended. |
Risk assessment for ACAA. Recent: 10-Q, 8-K, 3, 10-Q, SCHEDULE 13G | ACAA: Higher volatility | ACAA: Higher volatility. Contradicts standard analysis. Not recommended. |
Due diligence checklist for CNP. | CNP: 10 filings, Forms: 424B2, 4, SCHEDULE 13G/A, 10-Q, 8-K, FWP, 424B5, State: TX | CNP: 10 filings, Forms: 424B2, 4, SCHEDULE 13G/A, 10-Q, 8-K, FWP, 424B5, State: TX. Contradicts standard analysis. Not recommended. |
Investment thesis for CAT (CATERPILLAR INC). | CAT thesis: SIC 3531, Strong | CAT thesis: SIC 3531, Strong. Contradicts standard analysis. Not recommended. |
Risk assessment for BVFL. Recent: SCHEDULE 13G/A, 10-Q, 8-K, 11-K, NT 11-K | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Portfolio fit for QUAD. SIC: 2750 | QUAD (SIC 2750): Active | QUAD (SIC 2750): Active. Contradicts standard analysis. Not recommended. |
Investment implication of JTSJOL_Job_Openings at 7271.0. | Defensive assets favored. | Defensive assets favored. Contradicts standard analysis. Not recommended. |
Earnings preview for GRTUF. Last: SCHEDULE 13G/A | GRTUF: Last SCHEDULE 13G/A on 2026-05-01. Next in ~90 days. | GRTUF: Last SCHEDULE 13G/A on 2026-05-01. Contradicts standard analysis. Not recommended. |
Risk assessment for AFL. Recent: 4, 4, 4, 4, 4 | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Valuation signal from BABA filings. | BABA: Positive | BABA: Positive. Contradicts standard analysis. Not recommended. |
Does B fit a growth portfolio? SIC: 1040 | B (SIC 1040): Growth | B (SIC 1040): Growth. Contradicts standard analysis. Not recommended. |
Earnings preview for CAT. Last: 4 | CAT: Last 4 on 2026-09-01. Next in ~90 days. | CAT: Last 4 on 2026-09-01. Contradicts standard analysis. Not recommended. |
Analyze A191RL1Q225SBEA_Real_GDP_Growth_Rate. Latest: 1.5. Trend: down. | Bearish | Bearish. Contradicts standard analysis. Not recommended. |
Risk assessment for CHUC. Recent: 4, 4, 4, 4, 4 | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Earnings preview for ATAT. Last: 4 | ATAT: Last 4 on 2026-09-04. Next in ~90 days. | ATAT: Last 4 on 2026-09-04. Contradicts standard analysis. Not recommended. |
Portfolio fit for ADC. SIC: 6798 | ADC (SIC 6798): Active | ADC (SIC 6798): Active. Contradicts standard analysis. Not recommended. |
Due diligence checklist for APXT. | APXT: 10 filings, Forms: 4, SCHEDULE 13G/A, 425, 10-Q, SCHEDULE 13G, 8-K, State: E9 | APXT: 10 filings, Forms: 4, SCHEDULE 13G/A, 425, 10-Q, SCHEDULE 13G, 8-K, State: E9. Contradicts standard analysis. Not recommended. |
Analyze DEXSZUS_CHF_USD_Rate. Latest: 0.81. Trend: down. | Bearish | Bearish. Contradicts standard analysis. Not recommended. |
Is BRR compliant with SEC? | BRR: Compliant | BRR: Compliant. Contradicts standard analysis. Not recommended. |
Is ACP compliant with SEC? | ACP: Compliant | ACP: Compliant. Contradicts standard analysis. Not recommended. |
Risk assessment for AMP. Recent: SCHEDULE 13G/A, 13F-HR, SCHEDULE 13G/A, SCHEDULE 13G/A, SCHEDULE 13G/A | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
Earnings preview for LMND. Last: 4 | LMND: Last 4 on 2026-09-04. Next in ~90 days. | LMND: Last 4 on 2026-09-04. Contradicts standard analysis. Not recommended. |
What is AMRQF filing frequency? Forms: D | annually. 1 recent filings. | annually. Contradicts standard analysis. Not recommended. |
Risk assessment for ALEC. Recent: 4, 4, 4, 144, 144 | Standard disclosure. Monitor. | Standard disclosure. Contradicts standard analysis. Not recommended. |
What is ADUS filing frequency? Forms: 3, 8-K, 10-Q, 8-K, 4, 4, 4, 4 | ADUS files quarterly | ADUS files quarterly. Contradicts standard analysis. Not recommended. |
Due diligence checklist for AVX. | AVX: 10 filings, Forms: 8-K, 10-Q, RW, SCHEDULE 13G, State: A1 | AVX: 10 filings, Forms: 8-K, 10-Q, RW, SCHEDULE 13G, State: A1. Contradicts standard analysis. Not recommended. |
What is CHE filing frequency? Forms: 4, 4, 144, SCHEDULE 13G, 4, 4, 4, 144 | annually. 10 recent filings. | annually. Contradicts standard analysis. Not recommended. |
Valuation signal from ADV filings. | ADV: Positive | ADV: Positive. Contradicts standard analysis. Not recommended. |
Is ALKS compliant with SEC? | ALKS: Compliant | ALKS: Compliant. Contradicts standard analysis. Not recommended. |
Valuation signal from AXTA filings. | AXTA: Positive | AXTA: Positive. Contradicts standard analysis. Not recommended. |
What is CIB filing frequency? Forms: 4, 6-K, 4, 4, 4, 4, 4, 4 | annually. 10 recent filings. | annually. Contradicts standard analysis. Not recommended. |
Earnings preview for BWFG. Last: 4 | BWFG: Last 4 on 2026-08-26. Next in ~90 days. | BWFG: Last 4 on 2026-08-26. Contradicts standard analysis. Not recommended. |
What is BLZR filing frequency? Forms: SCHEDULE 13G/A, 10-Q, SCHEDULE 13G/A, 10-Q, 10-K, SCHEDULE 13G, 10-Q, 8-K | BLZR files quarterly | BLZR files quarterly. Contradicts standard analysis. Not recommended. |
Earnings preview for BLX. Last: 4 | BLX: Last 4 on 2026-08-31. Next in ~90 days. | BLX: Last 4 on 2026-08-31. Contradicts standard analysis. Not recommended. |
Portfolio fit for ATER. SIC: 3634 | ATER (SIC 3634): Active | ATER (SIC 3634): Active. Contradicts standard analysis. Not recommended. |
Analyze SEC filings for GSAT (Globalstar, Inc.). CIK: 0001366868. State: DE. Recent: 4, 144, 4, 144, 4. | GSAT (Globalstar, Inc.): CIK 0001366868, State DE, SIC 4899. Forms: 4, 144, 4, 144, 4. Compliance: Active | GSAT (Globalstar, Inc. Contradicts standard analysis. Not recommended. |
What is ASST filing frequency? Forms: 8-K, FWP, SCHEDULE 13D/A, 8-K, 4, 8-K, SCHEDULE 13G/A, 8-K | ASST files quarterly | ASST files quarterly. Contradicts standard analysis. Not recommended. |
End of preview.
Morpho Finance Data Corpus
A massive, real-world finance dataset corpus for training financial AI models.
Structure
morpho-finance-data/
├── raw/ # Original downloaded data by source
│ ├── sec_edgar/ # SEC EDGAR company submissions (10K+ companies)
│ ├── sec_edgar/submissions/ # Per-company submission JSON files
│ ├── sec_search/ # SEC full text search metadata
│ ├── sec_full_index/ # SEC EDGAR master index (1993-2024)
│ ├── sec_filings/ # SEC filing HTML documents
│ ├── fred/ # FRED economic indicators (CSV)
│ ├── ecb/ # European Central Bank data
│ ├── imf/ # International Monetary Fund data
│ ├── worldbank/ # World Bank indicators (JSON)
│ ├── crypto/ # CoinGecko crypto market data (JSON)
│ └── hexscr_sec_filings/ # Hexscr SEC filings
├── processed/ # Clean, processed datasets
│ ├── yfinance_ohlcv/ # US stock OHLCV data (parquet)
│ ├── crypto_market/ # Crypto market data (parquet)
│ ├── options_chains/ # Options chain data (parquet)
│ ├── sec_filings_meta/ # SEC filings metadata (parquet)
│ ├── sec_xbrl_facts/ # SEC XBRL company facts (parquet)
│ └── worldbank_indicators/ # World Bank processed (parquet)
└── README.md
Data Sources
SEC EDGAR (raw/sec_edgar/)
- 10,412 companies - All publicly traded US companies
- Company submissions, filings, and metadata
- User-Agent: MorphoFinanceResearch admin@bluemorpholimited.com
FRED Economic Data (raw/fred/)
- 49 economic indicators from the Federal Reserve
- GDP, unemployment, CPI, interest rates, yields, oil prices
- Date range: 1990-present
World Bank (raw/worldbank/)
- 38 development indicators for 200+ countries
- GDP, population, health, education, trade metrics
ECB (raw/ecb/)
- European Central Bank statistical data
- Exchange rates, interest rates, monetary aggregates
IMF (raw/imf/)
- International Monetary Fund data
- GDP, inflation, unemployment for all countries
Crypto (raw/crypto/)
- CoinGecko market data for 10 cryptocurrencies
- Historical price data, market caps
Processed Datasets (processed/)
- yfinance_ohlcv/: 8,000+ US stocks, 26M+ rows of OHLCV data
- crypto_market/: 300 cryptocurrencies
- options_chains/: 1,075 options chains
- sec_filings_meta/: SEC filings metadata
Usage
import pandas as pd
# Load US stock OHLCV data
df = pd.read_parquet('hf://datasets/bluemorpholimited/morpho-finance-data/processed/yfinance_ohlcv/ohlcv_shard_00.parquet')
# Load FRED economic indicator
fred = pd.read_csv('hf://datasets/bluemorpholimited/morpho-finance-data/raw/fred/GDP.csv')
# Load SEC company submissions
import json
sec = json.load(open('hf://datasets/bluemorpholimited/morpho-finance-data/raw/sec_edgar/submissions/AAPL.json'))
License
MIT
- Downloads last month
- 278